News
Public · Published
Galenica successfully places a bond of over CHF 200 million
Galenica placed a fixed rate bond of over CHF 200 million with a 4-year term and a 1.2775% annual coupon. The income will refinance a maturing bond and fund general corporate purposes, with Deutsche Bank and Zürcher Kantonalbank as joint lead managers.
Published:
Updated:
What happened
Galenica placed a fixed rate bond of over CHF 200 million with a 4-year term and a 1.2775% annual coupon. The income will refinance a maturing bond and fund general corporate purposes, with Deutsche Bank and Zürcher Kantonalbank as joint lead managers.
Confirmed
Global impact / market context
The bond gives Galenica over CHF 200 million in borrowed money at a fixed cost, which means interest payments stay predictable. Using it to repay an older bond pushes back repayment and may lower financing costs, freeing cash available for running the healthcare network.
Analyst inference
The issue shows a healthcare network can still raise borrowed money on fixed terms, and applying to trade on the SIX Swiss Exchange would let investors buy and sell the bond. The co-manager role and 1.2775% coupon signal demand among banks.
Analyst inference
What to watch
- Watch whether the application for admission to trading on the SIX Swiss Exchange is approved, which would let investors buy and sell the bond on a public exchange. Proposed
- Watch Galenica's coming sales update and annual results for signs of revenue and costs that affect how easily the company covers its interest payments. Analyst inference
- Watch the 21 January 2027 sales update 2026 and the 09 March 2027 annual results, both scheduled dates that could show the company's financial health after the refinancing. Confirmed